查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197355

关节重建设备市场-增长、趋势和预测 (2023-2028)

Joint Reconstruction Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，联合重建设备市场预计将以 6.55% 的复合年增长率註册。

由于择期手术的取消，COVID-19 正在影响关节重建设备市场。 例如，2021 年 4 月发表在 J.Arthroplasty 上的一篇文章报导说，COVID-19 大流行对关节成形术实践产生了重大影响。 该论文还报告说，大流行期间发生了许多髋关节和膝关节置换术取消，直接影响了关节重建设备市场。 因此，初期市场受疫情制约，面临较大困难。 然而，随着政府限制的放鬆和医疗服务的重新开放，该市场经历了显着增长。

推动这一市场增长的主要因素是骨科疾病患病率增加、人口老龄化加剧、对微创技术的偏好增加、大型关节重建手术数量增加等。 随着关节炎、骨质疏鬆、膝关节损伤等骨科疾病患病率的增加，导致严重的骨损伤，关节重建手术已成为最终的治疗手段。 例如，英国 2021 年 12 月发布的与工作相关的肌肉骨骼疾病统计数据估计，2020/21 年将有 470 万工人患有与工作相关的肌肉骨骼疾病（新的或长期的）。据报导， 这相当于每 100,000 名工人中有 1,420 例，因此占所有与工作有关的疾病的 28%。

同样，2021 年 1 月发表在 PTJ 上的另一篇论文报告说，在美国，肌肉骨骼疾病是与日常生活和获得报酬相关的残疾和限制的最常见原因。我在这里。 因此，膝盖和臀部等肌肉骨骼疾病的流行增加了对关节置换手术的需求。 这正在推动市场的增长。

随着老年人口的增加，骨骼脆弱的可能性增加，因此预计研究的市场也会增长。 老年人更容易患关节相关疾病，因此需要进行关节重建手术，这推动了关节重建设备的市场。 例如，2022 年 1 月发表在《J. Am. Acad. Orthop. Surg》杂誌上的一篇论文。推动市场的增长。

此外，微创手术的引入（疼痛更轻、住院时间更短、并发症更少）以及这种手术方法的广泛使用都有助于关节置换设备市场的增长。 例如，2022 年 5 月，富里总理报告了一种解决髋关节和膝关节置换手术积压问题的新方法。 通过改进围手术期短效麻醉、微创手术技术和术后立即启动康復方案，它也可以作为门诊手术。 因此，技术进步进一步推动了市场的增长。

此外，大型关节重建手术的增加也推动了所研究市场的增长。 例如，2021 年 11 月，美国骨科医师学会的分支机构 AJRR 在其 2021 年髋关节和膝关节置换术手术趋势年度报告中宣布，与上一年（2020 年）相比，累计手术总数有所增加。报告增长了 18.3%。 因此，联合重建手术的增加正在推动所研究市场的增长。

因此，由于上述原因，预计市场在预测期内将出现显着增长。 然而，由于对替代疗法的认识不断提高，严格的监管改革和监管问题可能会阻碍所研究市场的增长。

关节重建设备的市场趋势

关节置换设备领域预计在预测期内显着增长

由于老年人口的增加、膝关节退行性疾病的增加以及技术的发展，预计关节置换设备部分在预测期内将出现显着增长。

全球关节置换手术的增加促进了这一领域的发展。 例如，发表在 J. Orthop. Surg. Res. 杂誌上的一篇论文预计到 2030 年将增长 673%。因此，对关节置换手术的高需求正在推动该行业的增长。

同样，全球日益老龄化的人口也在推动这一细分市场的增长。 由于老年人口在关节手术中更为普遍，他们不断增加的人口预计将推动研究市场的增长。 例如，联合国 2022 概况报导称，到 2022 年，世界上约有 9.7% 的人口将超过 65 岁，而这一数字预计到 2050 年将增加 16.4%。 因此，大量老龄化人口正在推动这一细分市场的增长。

医疗设备的安全性和有效性、产品发布、併购以及合作伙伴关係等技术进步正在推动这一细分市场的增长。 例如，2022 年 7 月，Enovis 推出了一款用于膝关节和髋关节置换手术的可穿戴设备。 该系统是唯一专有的实时、免提增强现实 (AR) 技术，旨在为骨科医生进行髋关节和膝关节手术时提供精确的可视化指导。据说。 同样，2022 年 4 月，印度一家医院将引进 CUVIS 第 3 代主动式全自动关节置换系统。 因此，此类技术进步正在推动该细分市场的增长。

因此，由于上述原因，预计该部分在预测期内将出现重大变化。

预计在预测期内北美将显着增长

由于手术数量的增加、骨科疾病日益增多的老龄化社会的到来以及对微创手术的偏好，预计北美在预测期内将出现显着增长。

该地区越来越多的关节手术正在推动市场的增长。 例如，2022 年 2 月发表在《今日关节成形术》(Arthroplasty Today) 上的一篇文章报导，AJRR 2021 在过去十年中占了 2,244,587 例初次和翻修髋关节和膝关节置换术。 大多数手术是全膝关节置换术（54.5%）和全髋关节置换术（38.6%）。 女性患者占所有手术的58.5%，男性患者占38.6%。 该论文报告称，与往年相比，这些手术数量显着增加。 老年人更有可能接受这些手术。 因此，大量的关节置换手术正在推动该地区该市场的增长。

由于人口老龄化和技术发展，北美的另外两个国家加拿大和墨西哥也在推动市场增长。 2022 年 4 月，加拿大统计局报告称，该国 65 岁及以上的人口有 730 万。 85 岁以上的人口在过去六年中也增长了 12%，成为增长最快的年龄组之一。 因此，不断增长的老年人口导致关节重建手术的增加，这是推动该地区市场研究的一个因素。

主要市场参与者的技术进步正在推动该地区该市场的增长。 例如，2022 年 10 月，Orthofix 和 SeaSpine 对等合併，组成一家全球脊柱和骨科公司。 合併后的公司将成为一家全球脊柱和骨科公司。 它将拥有高度互补的生物製剂、创新脊柱硬件、骨骼生长疗法、骨科专业解决方案和手术导航系统的产品组合。

因此，由于上述因素，预计该地区在预测期内将出现显着增长。

关节重建设备市场竞争对手分析

关节重建设备市场由许多区域和全球参与者主导，包括 B. Braun GmbH (Aesculap Implant Systems LLC)、Conmed Corporation、Johnson and Johnson (DePuy Synthes Inc.) 和 Donjoy Inc。存在市场参与者的增多导致了一个分散且竞争激烈的市场。 区域和全球合作伙伴，例如 Supply and Services Inc.、Medtronic Inc.、Nuvasive Inc.、Smith & Nephew PLC、Stryker Corporation、Wright Medical Technology Inc、Zimmer Biomet Holdings Inc、AAP Implantate AG、Allegra Orthopedics Limited、Alphatec Spine Inc.包括位于

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 骨科疾病增加
    • 人口老龄化加剧
    • 越来越喜欢微创技术
    • 大关节重建手术增加
  • 市场製约因素
    • 对替代疗法的认识不断提高
    • 严格的监管改革
    • 监管问题
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按设备类型
    • 关节置换装置
    • 截骨装置
    • 关节镜设备
    • 重铺设备
    • 人工关节置换设备
    • 其他设备
  • 按关节类型
    • 膝关节
    • 髋关节
    • 肩关节
    • 脚踝
    • 其他关节
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • B. Braun GmbH（Aesculap Implant Systems LLC）
    • Conmed Corporation
    • Johnson and Johnson（DePuy Synthes Inc.）
    • Donjoy Inc. Supply and Services Inc.
    • Medtronic Inc.
    • Nuvasive Inc.
    • Smith & Nephew PLC
    • Stryker Corporation
    • Wright Medical Technology Inc.
    • Zimmer Biomet Holdings Inc.
    • AAP Implantate AG
    • Allegra Orthopaedics Limited
    • Alphatec Spine Inc.

第7章 市场机会与今后动向

简介目录
Product Code: 66062

The joint reconstruction devices market is expected to witness a CAGR of 6.55% during the forecast period.

COVID-19 had impacted the joint reconstruction devices market due to the cancellation of elective surgeries. For instance, an article published in J. Arthroplasty in April 2021 reported that the COVID-19 pandemic significantly affected arthroplasty practice. The article also reported the cancellation of many hip and knee arthroplasty services during the pandemic, which directly impacted the joint reconstruction devices market. Thus, initially, the market faced significant challenges due to the pandemic restrictions. However, with the ease of government regulations and the resumption of healthcare services the market witnessed significant growth.

The key factors propelling the growth of the market studied are the growing prevalence of orthopedic diseases, the increasing aging population, the increasing preference for minimally invasive techniques, and an increasing number of large joint reconstruction surgeries. With the growing prevalence of orthopedic diseases such as arthritis, osteoporosis, knee injuries, etc., resulting in damage to bones and serious cases, joint reconstruction surgery is the ultimate treatment available. For instance, in December 2021, Work-Related Musculoskeletal Disorders Statistics in Great Britain reported that 4,70,000 workers suffered from work-related musculoskeletal disorders (new or long-standing) in 2020/21. This represents 1,420 per 100,000 workers and thus accounts for 28% of all work-induced ill health.

Similarly, another article published by the journal PTJ in January 2021 reported that musculoskeletal conditions are the most common causes of disability and limitations related to daily living and gainful employment in the United States. Thus, a high number of musculoskeletal conditions, including knee, hip, and other joint conditions, increase the demand for joint replacement surgical procedures. This is propelling the market's growth.

As the geriatric population increases, the market studied is also expected to grow as weak bones are more likely to develop in the geriatric population. Joint-related disorders are more likely to arise in the geriatric population, resulting in the need for joint reconstruction surgery, thereby driving the market for joint reconstruction devices. For instance, an article published in the journal, J. Am. Acad. Orthop. Surg. in January 2022 reported a higher prevalence of joint pain among the older population. Thus, with increasing aging, individuals become more susceptible to orthopedic diseases, leading to increasing joint surgery, thereby driving the growth of the market studied.

Also, the introduction of minimally invasive surgery, which is associated with less pain, a shorter hospital stay, and fewer complications, and the increasing use of this surgical procedure are contributing to the growth of the joint replacement devices market. For instance, in May 2022, Premier Furey reported a new approach to address surgical backlogs for hip and knee replacement surgeries. Also, improved perioperative short-acting anesthesia, minimally invasive surgical techniques, and the initiation of rehabilitation protocols soon after surgery have made this surgery possible as an outpatient procedure. As a result, technological advancements are further propelling the growth of the market studied.

Furthermore, the increasing number of large joint reconstruction surgeries is also propelling the growth of the studied market. For instance, in November 2021, the AJRR, the cornerstone of the American Academy of Orthopaedic Surgeons in its 2021 Annual Report on hip and knee arthroplasty procedural trends, reported an overall cumulative procedural volume growth of 18.3% compared to the previous year, 2020. Thus, the increasing number of joint reconstruction surgeries is driving the growth of the market studied.

Thus, for the aforesaid reasons, the market is expected to witness significant growth during the forecast period. However, due to increased awareness about alternative treatments, stringent regulatory reforms and regulatory issues may hamper the growth of the market studied.

Joint Reconstruction Devices Market Trends

Joint Replacement Devices Segment is Expected to Witness a Significant Growth Over the Forecast Period.

The joint replacement devices segment is expected to witness significant growth over the forecast period owing to the increase in the geriatric population, the increase in degenerative knee diseases, and technological developments.

The increasing number of joint replacement surgery occurring globally is contributing to the growth of this segment. For instance, an article published in the journal, J. Orthop. Surg. Res., in October 2022, reported a significant increase in the number of osteosynthesis implants and joint replacement implants in the past decade, and the demand for knee replacement in the United States is expected to increase by 673% by 2030. Thus, the high demand for joint replacement surgery is propelling the growth of this segment.

Similarly, the increasing geriatric population globally is also propelling the growth of this segment, as the geriatric population is more prevalent in joint surgeries and the increasing their increasing population is expected to drive the growth of the studied market. For instance, United Nations 2022, factsheet reported that in 2022, about 9.7% population in the world aged 65 and above, and this number is expected to increase by 16.4% by 2050. Thus, the high geriatric population is propelling the growth of this segment.

The safety and efficacy of medical devices and technological advancements such as product launches, mergers, acquisitions, and partnerships are propelling the growth of this segment. For instance, in July 2022, Enovis launched a wearable device for knee and hip replacement. The system is said to be the only proprietary, real-time, hands-free augmented reality (AR) technology that has been developed to provide orthopedic surgeons with precision guidance visualization while performing hip and knee surgery. Similarly, in April 2022, a joint replacement device CUVIS third generation active and fully automated joint replacement system in one of the hospitals in India. Thus, such technological advancements is driving the growth of the segment.

Thus, due to the aforesaid reasons, the segment is expected to witness a significant over the forecast period.

North America is Expected to Witness a Significant Growth Over the Forecast Period

North America is expected to witness significant growth during the forecast period due to the increasing number of surgeries, the rising aging population with increasing orthopedic conditions, and the preference toward minimally invasive procedures.

The increasing number of joint surgeries in the region is propelling the growth of this market in the region. For instance, an article published in Arthroplasty Today in February 2022 reported that the AJRR 2021 accounted for 2,244,587 primary and revision hip and knee arthroplasties in the last decade. Most of the surgeries were primary total knee arthroplasty (54.5%) and primary total hip arthroplasty (38.6%). Female patients represented 58.5% of all procedures, while male patients represented 38.6% of all cases. The article reported a significant increase in these surgeries as compared to previous years. A high percentage of the geriatric population undergoes these surgical procedures. Thus, a high number of joint replacement surgical procedures is driving the growth of this market in the region.

The other two North American countries, Canada and Mexico, are also propelling the growth of the market owing to the increase in the geriatric population and technological development. In April 2022, Statistics Canada reported that there were 7.3 million people aged 65 and older in the country. Also, the population aged 85 and older is one of the fastest-growing age groups, with a 12% increase in the last six years. Thus, an increasing geriatric population is associated with an increase in joint reconstruction surgery, thereby propelling the market studied in the region.

Technological advancements by key market players are propelling the growth of this market in the region. For instance, in October 2022, Orthofix and SeaSpine combined in a merger of equals to create a global spine and orthopedics company. The combined company will be a global spine and orthopedics company. It will have highly complementary portfolios of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a surgical navigation system.

Thus, due to the above-mentioned factors, the region is expected to witness significant growth during the forecast period.

Joint Reconstruction Devices Market Competitor Analysis

The joint reconstruction devices market is fragmented and competitive due to the presence of many market players present regionally and globally such as B. Braun GmbH (Aesculap Implant Systems LLC), Conmed Corporation, Johnson and Johnson (DePuy Synthes Inc.), Donjoy Inc. Supply and Services Inc., Medtronic Inc., Nuvasive Inc., Smith & Nephew PLC, Stryker Corporation, Wright Medical Technology Inc., Zimmer Biomet Holdings Inc., AAP Implantate AG, Allegra Orthopaedics Limited, and Alphatec Spine Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of Orthopedic Diseases
    • 4.2.2 Increasing Aging Population
    • 4.2.3 Increasing Preference for Minimally Invasive Techniques
    • 4.2.4 Increasing Number of Large Joint Reconstruction Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Increase Awareness about Alternative Treatments
    • 4.3.2 Stringent Regulatory Reforms
    • 4.3.3 Regulatory Issues
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Device Type
    • 5.1.1 Joint Replacement Devices
    • 5.1.2 Osteotomy Devices
    • 5.1.3 Arthroscopy Devices
    • 5.1.4 Resurfacing Devices
    • 5.1.5 Arthrodesis Devices
    • 5.1.6 Other Device Types
  • 5.2 By Joint Type
    • 5.2.1 Knee
    • 5.2.2 Hip
    • 5.2.3 Shoulder
    • 5.2.4 Ankle
    • 5.2.5 Other Joint Types
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun GmbH (Aesculap Implant Systems LLC)
    • 6.1.2 Conmed Corporation
    • 6.1.3 Johnson and Johnson (DePuy Synthes Inc.)
    • 6.1.4 Donjoy Inc. Supply and Services Inc.
    • 6.1.5 Medtronic Inc.
    • 6.1.6 Nuvasive Inc.
    • 6.1.7 Smith & Nephew PLC
    • 6.1.8 Stryker Corporation
    • 6.1.9 Wright Medical Technology Inc.
    • 6.1.10 Zimmer Biomet Holdings Inc.
    • 6.1.11 AAP Implantate AG
    • 6.1.12 Allegra Orthopaedics Limited
    • 6.1.13 Alphatec Spine Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS